Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gliosarcoma × ficlatuzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 3 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Neoplasm Metastasis 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Vascular Diseases 1 Thoracic Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Recurrence 1 Pathologic Processes 1 Paraproteinemias 1 Oropharyngeal Neoplasms 1 Neoplastic Processes 1 Neoplasms, Plasma Cell 1 Neoplasms, Glandular and Epithelial 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lymphoproliferative Disorders 1 Lymphoma 1 Lymphoid Interstitial Pneumonia 1 Lymphatic Diseases 1 Lung Neoplasms 1 Lung Diseases 1 Liver Neoplasms 1 Liver Diseases 1 Lip Neoplasms 1

Interventions

Temozolomide 118 Radiotherapy 79 Bevacizumab 39 Radiation 30 Carmustine 25 Irinotecan 20 Erlotinib Hydrochloride 19 Magnetic Resonance Spectroscopy 18 Chemotherapy, Adjuvant 17 Surgical Procedures, Operative 13 Carboplatin 13 sargramostim 12 O(6)-benzylguanine 12 Radiotherapy, Intensity-Modulated 10 Radiotherapy, Conformal 10 Thalidomide 8 Imatinib Mesylate 8 Drug Therapy 8 Radiosurgery 7 Procarbazine 7 pembrolizumab 6 motexafin gadolinium 6 cediranib 6 Vorinostat 6 Lomustine 6 Gene Expression Profiling 6 Gefitinib 6 Filgrastim 6 Everolimus 6 Cyclophosphamide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01189513 2012-02-20

SCH-900105 in Recurrent Glioblastoma

M.D. Anderson Cancer Center

Phase 1 Withdrawn

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡